TrialCancer research and treatment2023

EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-mutated NSCLC: A Prospective, Randomized, Exploratory Study.

Weiguang Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.